Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

C. Roy Hardiman


  • Chief Business Officer at Principia Biopharma Inc. (PRNB), 2020-03-17
  • Director at Pharmacyclics Inc (PCYC), 2012-10-03
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PRNB $51.04 100 Officer 116,903 2020-03-13 Filing
PRNB $49.46 1,181 Officer 117,003 2020-03-13 Filing
PRNB $48.21 3,719 Officer 118,184 2020-03-13 Filing
PRNB $49.83 1,619 Officer 120,143 2019-12-13 Filing
PRNB $49.20 3,381 Officer 121,762 2019-12-13 Filing